MedPath

Spyre Therapeutics, LLC

Spyre Therapeutics, LLC logo
🇺🇸United States
Ownership
Public
Established
2013-01-01
Employees
101
Market Cap
$1.4B
Website
http://www.spyre.com

SPY003-207 in Health Volunteers

Phase 1
Recruiting
Conditions
Healthy
Interventions
Drug: SPY003-207
Other: Placebo
First Posted Date
2025-03-13
Last Posted Date
2025-03-13
Lead Sponsor
Spyre Therapeutics, Inc.
Target Recruit Count
64
Registration Number
NCT06873724
Locations
🇨🇦

Spyre Site 1, Montréal, Quebec, Canada

A Study of SPY002-091 in Healthy Volunteers

Phase 1
Recruiting
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2024-11-04
Last Posted Date
2024-11-06
Lead Sponsor
Spyre Therapeutics, Inc.
Target Recruit Count
56
Registration Number
NCT06672718
Locations
🇺🇸

Spyre Site 1, Cypress, California, United States

A Study of SPY002-072 in Healthy Volunteers

Phase 1
Recruiting
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2024-10-01
Last Posted Date
2024-11-27
Lead Sponsor
Spyre Therapeutics, Inc.
Target Recruit Count
56
Registration Number
NCT06622070
Locations
🇺🇸

Spyre Site 2, Cypress, California, United States

🇨🇦

Spyre Site 1, Montréal, Quebec, Canada

A Study of SPY001-001 in Healthy Volunteers

Phase 1
Active, not recruiting
Conditions
Healthy
Interventions
Other: Placebo
First Posted Date
2024-06-07
Last Posted Date
2025-02-26
Lead Sponsor
Spyre Therapeutics, Inc.
Target Recruit Count
96
Registration Number
NCT06448247
Locations
🇺🇸

Spyre Site 2, Cypress, California, United States

🇨🇦

Spyre Site 1, Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath